- Sixth Wave Innovations (SIXW) has commenced live virus testing for COVID-19 in saliva samples using its AMIPs™ technology
- The company expects this phase of development to be completed later this month
- Next steps for AMIPs™ testing include viral selectivity screening before applying for FDA and Health Canada regulatory approval
- The company expects to begin prototype production in the first half of 2022
- Sixth Wave is a nanotechnology company
- Shares in Sixth Wave Innovations Inc. (SIXW) are down 2.0 per cent, trading at $0.245 per share
Sixth Wave Innovations (SIXW) has commenced live virus testing for COVID-19 in saliva samples using its AMIPs™ technology.
The Accelerated Molecularly Imprinted Polymer (AMIPs) technology is a rapid diagnostic test designed to detect viruses at a molecular level.
With the help of researchers from the La Ki Shing Institute of Virology, Sixth Wave is using AMIPs™ to test saliva samples spiked with live SARS-CoV-2 virus.
Confirmation studies and additional advanced manufacturing techniques are ongoing. These new techniques will simplify the analysis process and Sixth Wave believes they will lead to improved sensitivity to interferent molecules in the complex saliva samples.
The company expects this phase of development to be completed later this month. Once the current phase is complete, the technology will be sent to third-party laboratories for validation.
The next steps for AMIPs™ testing include viral selectivity screening, which will involve testing the technology against a standardized panel of respiratory viruses to confirm that there is no cross-reactivity.
This cross-reactivity testing is the final step required before Sixth Wave can begin the application process for regulatory approval from the FDA and Health Canada.
The company expects to begin prototype production in the first half of 2022 once approval has been granted.
To date, AMIPs™ have proven very robust in the detection of variants and by design should continue to be relatively unaffected by mutations. The company believes that AMIPs™ represents a paradigm shift in testing.
Sixth Wave is a nanotechnology company with patented technologies that focus on the extraction and detection of target substances at the molecular level.
The company is in the process of a commercial rollout of its Affinity™ cannabinoid purification system, as well as IXOS®, a line of extraction polymers for the gold mining industry.
Shares in Sixth Wave Innovations Inc. (SIXW) are down 2.0 per cent, trading at $0.245 per share as of 10:26 am EST.
